New China Life Insurance Co (SHSE:601336) Current Deferred Revenue: ¥437 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:601336 New China Life Insurance Co Ltd SHSE:601336
69 GF Score
Price ¥58.54
GF Value ¥54.81
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is New China Life Insurance Co Current Deferred Revenue?

New China Life Insurance Co SHSE:601336 +0.62% 69 Current Deferred Revenue is ¥437 Mil as of Jun. 2026. GuruFocus rates SHSE:601336 with a GF Score™ of 69/100 and a GF Value™ of ¥54.81 (Fairly Valued). The stock has 2 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

New China Life Insurance Co's current deferred revenue for the quarter that ended in Jun. 2026 was ¥437 Mil.

New China Life Insurance Co Current Deferred Revenue Related Terms

New China Life Insurance Co Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for New China Life Insurance Co's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

New China Life Insurance Co Current Deferred Revenue Chart

New China Life Insurance Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,095.00 431.00 274.00 - -

New China Life Insurance Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 464.00 - 450.00 - 437.00
SHSE:601336
69GF Score
New China Life Insurance Co Ltd SHSE:601336
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of ¥437 Mil mean?
New China Life Insurance Co (SHSE:601336) has a Current Deferred Revenue of ¥437 Mil as of Jun. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on New China Life Insurance Co and its competitors.
Is New China Life Insurance Co's Current Deferred Revenue too high?
New China Life Insurance Co's current Current Deferred Revenue is ¥437 Mil. Overall, New China Life Insurance Co has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does New China Life Insurance Co's Current Deferred Revenue compare to MET and AFL?
New China Life Insurance Co's Current Deferred Revenue of ¥437 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for an Insurance company?
A good Current Deferred Revenue depends on the Insurance industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on New China Life Insurance Co and its competitors. New China Life Insurance Co's current Current Deferred Revenue is ¥437 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is New China Life Insurance Co stock overvalued right now?
Based on GuruFocus' analysis, New China Life Insurance Co (SHSE:601336) is currently considered Fairly Valued. The stock's GF Value™ is ¥54.81, compared to a current price of ¥58.54 — trading 6.8% above its estimated fair value. The current Current Deferred Revenue is ¥437 Mil. New China Life Insurance Co's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For New China Life Insurance Co (SHSE:601336), the current Current Deferred Revenue is ¥437 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is New China Life Insurance Co (SHSE:601336) Overvalued in 2026?

Based on GuruFocus' analysis, New China Life Insurance Co stock appears to be overvalued. The current stock price of ¥58.54 is trading 6.8% above its estimated GF Value™ of ¥54.81. GuruFocus considers New China Life Insurance Co to be Fairly Valued.

Key valuation signals for SHSE:601336:

  • Current Deferred Revenue: ¥437 Mil
  • GF Value™: ¥54.81 vs. price of ¥58.54 (6.8% above fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the SHSE:601336 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

New China Life Insurance Co Business Description

Address A12 Jianguomenwai Avenue, New China Insurance Tower, Chaoyang District, Beijing, CHN, 100022
New China Life Insurance Co Ltd is headquartered in Beijing and was established in 1996 by a combination of state-owned enterprises and private firms. It is currently the fourth-largest life insurer in China based on total assets. New China Life offers a wide range of life insurance products and services to both individual and institutional customers through its extensive distribution networks and diverse marketing channels. Additionally, it manages and invests insurance funds through its subsidiaries, including its Asset Management Company and Asset Management Company (Hong Kong).
69GF Score

Get the complete analysis for SHSE:601336

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥58.54
Price
¥54.81
GF Value